Geron
GERN
#6254
Rank
โ‚น76.62 B
Marketcap
โ‚น120.04
Share price
-0.75%
Change (1 day)
-61.54%
Change (1 year)

EPS for Geron (GERN)

EPS in 2025 (TTM): -โ‚น10.38

According to Geron's latest financial reports the company's current EPS (TTM) is -โ‚น10.83. In 2024 the company made an earnings per share (EPS) of -โ‚น24.37 an increase over its 2023 EPS that were of -โ‚น29.78.

EPS history for Geron from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น10.38-57.43%
2024-โ‚น24.37-18.18%
2023-โ‚น29.78-8.33%
2022-โ‚น32.49-0%
2021-โ‚น32.4933.33%
2020-โ‚น24.37-25%
2019-โ‚น32.49140%
2018-โ‚น13.54-16.67%
2017-โ‚น16.25-0%
2016-โ‚น16.25-1.2970366926827E+18%
2015โ‚น0.0000000000-100%
2014-โ‚น21.66
2012-โ‚น48.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,924 63,825.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น588.47-5,533.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น45.13-516.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น552.37-5,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น52.35 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA